Dried blood spot sampling in combination with LC-MS/MS for quantitative analysis of small molecules.

The collection of whole blood samples on paper, known as dried blood spot (DBS), dates back to the early 1960s in newborn screening for inherited metabolic disorders. DBS offers a number of advantages over conventional blood collection. As a less invasive sampling method, DBS offers simpler sample collection and storage and easier transfer, with reduced infection risk of various pathogens, and requires a smaller blood volume. To date, DBS-LC-MS/MS has emerged as an important method for quantitative analysis of small molecules. Despite the increasing popularity of DBS-LC-MS/MS, the method has its limitations in assay sensitivity due to the small sample size. Sample quality is often a concern. Systematic assessment on the potential impact of various blood sample properties on accurate quantification of analyte of interest is necessary. Whereas most analytes may be stable on DBS, unstable compounds present another challenge for DBS as enzyme inhibitors cannot be conveniently mixed during sample collection. Improvements on the chemistry of DBS card are desirable. In addition to capturing many representative DBS-LS-MS/MS applications, this review highlights some important aspects of developing and validating a rugged DBS-LC-MS/MS method for quantitative analysis of small molecules along with DBS sample collection, processing and storage.

[1]  A. Drash,et al.  Microfilter paper method for 17 alpha-hydroxyprogesterone radioimmunoassay: its application for rapid screening for congenital adrenal hyperplasia. , 1977, The Journal of clinical endocrinology and metabolism.

[2]  M. S. van der Knaap,et al.  Quantification of sugar phosphate intermediates of the pentose phosphate pathway by LC-MS/MS: application to two new inherited defects of metabolism. , 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[3]  U. Steuerwald,et al.  Newborn screening for congenital adrenal hyperplasia: additional steroid profile using liquid chromatography-tandem mass spectrometry. , 2007, The Journal of clinical endocrinology and metabolism.

[4]  E. Gunter,et al.  Evaluation of factors influencing precision in the analysis of samples taken from blood spots on filter paper. , 1995, Clinical and laboratory haematology.

[5]  Sharon Williams,et al.  What a drop can do: Dried blood spots as a minimally invasive method for integrating biomarkers into population-based research , 2007, Demography.

[6]  Kevin P Bateman,et al.  Discovery stage pharmacokinetics using dried blood spots. , 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[7]  J. D. den Burger,et al.  Analysis of cyclosporin A in dried blood spots using liquid chromatography tandem mass spectrometry. , 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[8]  E. Mayatepek,et al.  Accurate measurement of free carnitine in dried blood spots by isotope-dilution electrospray tandem mass spectrometry without butylation. , 2003, Clinica chimica acta; international journal of clinical chemistry.

[9]  K. Gempel,et al.  Rapid determination of total homocysteine in blood spots by liquid chromatography-electrospray ionization-tandem mass spectrometry. , 2000, Clinical chemistry.

[10]  F. Tsai,et al.  Rapid monitoring assay of congenital adrenal hyperplasia with microbore high-performance liquid chromatography/electrospray ionization tandem mass spectrometry from dried blood spots. , 2001, Rapid communications in mass spectrometry : RCM.

[11]  H. Rosing,et al.  Quantification of the HIV-integrase inhibitor raltegravir and detection of its main metabolite in human plasma, dried blood spots and peripheral blood mononuclear cell lysate by means of high-performance liquid chromatography tandem mass spectrometry. , 2009, Journal of pharmaceutical and biomedical analysis.

[12]  D. Chace,et al.  Steroid profiling by tandem mass spectrometry improves the positive predictive value of newborn screening for congenital adrenal hyperplasia. , 2004, The Journal of clinical endocrinology and metabolism.

[13]  J. V. van Hooff,et al.  Dried blood spot measurement: application in tacrolimus monitoring using limited sampling strategy and abbreviated AUC estimation , 2007, Transplant international : official journal of the European Society for Organ Transplantation.

[14]  Georg Heinze,et al.  Long-term stability of amino acids and acylcarnitines in dried blood spots. , 2007, Clinical chemistry.

[15]  S. Parker,et al.  The use of the dried blood spot sample in epidemiological studies. , 1999, Journal of clinical pathology.

[16]  M. S. van der Knaap,et al.  Profiling of pentose phosphate pathway intermediates in blood spots by tandem mass spectrometry: application to transaldolase deficiency. , 2003, Clinical chemistry.

[17]  E. Faqeih,et al.  Determination of succinylacetone in dried blood spots and liquid urine as a dansylhydrazone by liquid chromatography tandem mass spectrometry. , 2006, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[18]  P. Fernhoff,et al.  An evaluation of the use of dried blood spots from newborn screening for monitoring the prevalence of cocaine use among childbearing women. , 1997, Biochemical and molecular medicine.

[19]  R. Guerrini,et al.  Rapid assay of topiramate in dried blood spots by a new liquid chromatography-tandem mass spectrometric method. , 2008, Journal of pharmaceutical and biomedical analysis.

[20]  R. Fingerhut False positive rate in newborn screening for congenital adrenal hyperplasia (CAH)–ether extraction reveals two distinct reasons for elevated 17α-hydroxyprogesterone (17-OHP) values , 2009, Steroids.

[21]  A. Moser,et al.  Newborn screening for X-linked adrenoleukodystrophy (X-ALD): validation of a combined liquid chromatography-tandem mass spectrometric (LC-MS/MS) method. , 2009, Molecular genetics and metabolism.

[22]  Aurélien Thomas,et al.  On-line desorption of dried blood spot: A novel approach for the direct LC/MS analysis of micro-whole blood samples. , 2009, Journal of pharmaceutical and biomedical analysis.

[23]  Lijuan Zhang,et al.  Diagnosis of congenital adrenal hyperplasia by rapid determination of 17alpha-hydroxyprogesterone in dried blood spots by gas chromatography/mass spectrometry following microwave-assisted silylation. , 2005, Rapid communications in mass spectrometry : RCM.

[24]  G. Ellis,et al.  Identification of the steroids in neonatal plasma that interfere with 17 alpha-hydroxyprogesterone radioimmunoassays. , 1992, Clinical chemistry.

[25]  D. Millington,et al.  Rapid diagnosis of maple syrup urine disease in blood spots from newborns by tandem mass spectrometry. , 1995, Clinical chemistry.

[26]  K. Resch,et al.  Quantification of antiretroviral drugs in dried blood spot samples by means of liquid chromatography/tandem mass spectrometry. , 2005, Rapid communications in mass spectrometry : RCM.

[27]  H. Rosing,et al.  Quantification of etravirine (TMC125) in plasma, dried blood spots and peripheral blood mononuclear cell lysate by liquid chromatography tandem mass spectrometry. , 2009, Journal of pharmaceutical and biomedical analysis.

[28]  Y. Hsieh,et al.  Stabilizing Drug Molecules in Biological Samples , 2005, Therapeutic drug monitoring.

[29]  P. Rinaldo,et al.  Reduction of the false-positive rate in newborn screening by implementation of MS/MS-based second-tier tests: The Mayo Clinic experience (2004–2007) , 2007, Journal of Inherited Metabolic Disease.

[30]  R. Guerrini,et al.  A new rapid micromethod for the assay of phenobarbital from dried blood spots by LC‐tandem mass spectrometry , 2009, Epilepsia.

[31]  G. Mitchell,et al.  Quantitative determination of succinylacetone in dried blood spots for newborn screening of tyrosinemia type I. , 2006, Molecular genetics and metabolism.

[32]  H. Yoon Two Step Derivatization for the Analyses of Organic, Amino Acids and Glycines on Filter Paper Plasma by GC-MS/SIM , 2007, Archives of pharmacal research.

[33]  H. Yu,et al.  Utilization of Dried Blood Spot Citrulline Level as a Noninvasive Method for Monitoring Graft Function Following Intestinal Transplantation , 2005, Transplantation.

[34]  L. Stolk,et al.  Therapeutic drug monitoring of everolimus using the dried blood spot method in combination with liquid chromatography-mass spectrometry. , 2009, Journal of pharmaceutical and biomedical analysis.

[35]  V. Wiley,et al.  Application of tandem mass spectrometry to biochemical genetics and newborn screening. , 2002, Clinica chimica acta; international journal of clinical chemistry.

[36]  Hugo Moser,et al.  Combined liquid chromatography-tandem mass spectrometry as an analytical method for high throughput screening for X-linked adrenoleukodystrophy and other peroxisomal disorders: preliminary findings. , 2006, Molecular genetics and metabolism.

[37]  T. Brandon,et al.  A Liquid Chromatography/Tandem Mass Spectrometry Method for Determination of 25-Hydroxy Vitamin D2 and 25-Hydroxy Vitamin D3 in Dried Blood Spots: A Potential Adjunct to Diabetes and Cardiometabolic Risk Screening , 2009, Journal of diabetes science and technology.

[38]  S. J. Smith,et al.  Recoveries of phenylalanine from two sets of dried-blood-spot reference materials: prediction from hematocrit, spot volume, and paper matrix. , 2000, Clinical chemistry.

[39]  B. Casetta,et al.  Improved specificity of newborn screening for congenital adrenal hyperplasia by second-tier steroid profiling using tandem mass spectrometry. , 2004, Clinical chemistry.

[40]  M. Barfield,et al.  Study of dried blood spots technique for the determination of dextromethorphan and its metabolite dextrorphan in human whole blood by LC-MS/MS. , 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[41]  Joerg Henseler,et al.  Determination of Morphine and 6-Acetylmorphine in Blood With Use of Dried Blood Spots , 2008, Therapeutic drug monitoring.

[42]  M. Peter,et al.  Fast and direct quantification of adrenal steroids by tandem mass spectrometry in serum and dried blood spots. , 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[43]  O. Al-Dirbashi,et al.  Improved method to determine succinylacetone in dried blood spots for diagnosis of tyrosinemia type 1 using UPLC-MS/MS. , 2008, Biomedical chromatography : BMC.

[44]  Yukie Tanaka,et al.  Stable-isotope dilution measurement of isovalerylglycine by tandem mass spectrometry in newborn screening for isovaleric acidemia. , 2007, Clinica chimica acta; international journal of clinical chemistry.

[45]  D. Chace,et al.  The application of tandem mass spectrometry to neonatal screening for inherited disorders of intermediary metabolism. , 2002, Annual review of genomics and human genetics.

[46]  L. Stolk,et al.  Dried Blood Spot Methods in Therapeutic Drug Monitoring: Methods, Assays, and Pitfalls , 2009, Therapeutic drug monitoring.

[47]  D. Millington,et al.  Rapid diagnosis of phenylketonuria by quantitative analysis for phenylalanine and tyrosine in neonatal blood spots by tandem mass spectrometry. , 1993, Clinical chemistry.

[48]  J V Mei,et al.  Use of filter paper for the collection and analysis of human whole blood specimens. , 2001, The Journal of nutrition.

[49]  D. L. Norwood,et al.  Tandem mass spectrometry: A new method for acylcarnitine profiling with potential for neonatal screening for inborn errors of metabolism , 1990, Journal of Inherited Metabolic Disease.

[50]  R. Guthrie,et al.  A SIMPLE PHENYLALANINE METHOD FOR DETECTING PHENYLKETONURIA IN LARGE POPULATIONS OF NEWBORN INFANTS. , 1963, Pediatrics.

[51]  G. Heinze,et al.  Stability of 17alpha-hydroxyprogesterone in dried blood spots after autoclaving and prolonged storage. , 2002, Clinical chemistry.

[52]  P. Mortensen,et al.  A sensitive LC/MS/MS assay of 25OH vitamin D3 and 25OH vitamin D2 in dried blood spots. , 2009, Clinica chimica acta; international journal of clinical chemistry.

[53]  B. Casetta,et al.  Progress in expanded newborn screening for metabolic conditions by LC-MS/MS in Tuscany: Update on methods to reduce false tests , 2008, Journal of Inherited Metabolic Disease.

[54]  O. Müller,et al.  Quantification of cationic anti-malaria agent methylene blue in different human biological matrices using cation exchange chromatography coupled to tandem mass spectrometry. , 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[55]  J. Hooff,et al.  Therapeutic drug monitoring of tacrolimus with the dried blood spot method. , 2007, Journal of pharmaceutical and biomedical analysis.

[56]  J. Steghens,et al.  ESI-MS/MS analysis of underivatised amino acids: a new tool for the diagnosis of inherited disorders of amino acid metabolism. Fragmentation study of 79 molecules of biological interest in positive and negative ionisation mode. , 2003, Rapid communications in mass spectrometry : RCM.

[57]  D. Johnson,et al.  Stability of malonylcarnitine and glutarylcarnitine in stored blood spots , 2004, Journal of Inherited Metabolic Disease.

[58]  P. Fernhoff,et al.  Analysis of benzoylecgonine in dried blood spots by liquid chromatography--atmospheric pressure chemical ionization tandem mass spectrometry. , 1996, Journal of analytical toxicology.

[59]  R. Steiner,et al.  Tandem mass spectrometry in newborn screening: a primer for neonatal and perinatal nurses. , 2004, The Journal of perinatal & neonatal nursing.

[60]  P. Rinaldo,et al.  Recent developments and new applications of tandem mass spectrometry in newborn screening , 2004, Current opinion in pediatrics.

[61]  Y. Shigematsu,et al.  Modifications in electrospray tandem mass spectrometry for a neonatal-screening pilot study in Japan. , 1999, Journal of chromatography. B, Biomedical sciences and applications.

[62]  U. Garg,et al.  Expanded newborn screening of inherited metabolic disorders by tandem mass spectrometry: clinical and laboratory aspects. , 2006, Clinical biochemistry.

[63]  G. la Marca,et al.  The inclusion of succinylacetone as marker for tyrosinemia type I in expanded newborn screening programs. , 2008, Rapid communications in mass spectrometry : RCM.

[64]  F. Tsai,et al.  Rapid screening assay of congenital adrenal hyperplasia by measuring 17α‐hydroxyprogesterone with high‐performance liquid chromatography/electrospray ionization tandem mass spectrometry from dried blood spots , 2002, Journal of clinical laboratory analysis.

[65]  N. Chamoles,et al.  Diagnosis of isovaleric acidaemia by tandem mass spectrometry: False positive result due to pivaloylcarnitine in a newborn screening programme , 1998, Journal of Inherited Metabolic Disease.

[66]  S. McCann,et al.  Measurement of total homocysteine in plasma and blood spots using liquid chromatography-tandem mass spectrometry: comparison with the plasma Abbott IMx method , 2003, Annals of clinical biochemistry.

[67]  A. A. Alfazil,et al.  Stability of benzodiazepines and cocaine in blood spots stored on filter paper. , 2008, Journal of analytical toxicology.

[68]  G. Heinze,et al.  Influence of hematocrit and localisation of punch in dried blood spots on levels of amino acids and acylcarnitines measured by tandem mass spectrometry. , 2006, Clinica chimica acta; international journal of clinical chemistry.

[69]  M. Barfield,et al.  Dried blood spots as a sample collection technique for the determination of pharmacokinetics in clinical studies: considerations for the validation of a quantitative bioanalytical method. , 2009, Analytical chemistry.

[70]  T. Higashi,et al.  Simultaneous determination of 17alpha-hydroxypregnenolone and 17alpha-hydroxyprogesterone in dried blood spots from low birth weight infants using LC-MS/MS. , 2008, Journal of pharmaceutical and biomedical analysis.

[71]  S. O'broin Influence of hematocrit on quantitative analysis of "blood spots" on filter paper. , 1993, Clinical chemistry.

[72]  H. Rosing,et al.  Quantification of protease inhibitors and non-nucleoside reverse transcriptase inhibitors in dried blood spots by liquid chromatography-triple quadrupole mass spectrometry. , 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[73]  G. la Marca,et al.  Rapid 2nd-tier test for measurement of 3-OH-propionic and methylmalonic acids on dried blood spots: reducing the false-positive rate for propionylcarnitine during expanded newborn screening by liquid chromatography-tandem mass spectrometry. , 2007, Clinical chemistry.

[74]  Neil Spooner,et al.  Application of dried blood spots combined with HPLC-MS/MS for the quantification of acetaminophen in toxicokinetic studies. , 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[75]  R. Fingerhut,et al.  Newborn screening for inborn errors of metabolism and endocrinopathies: an update , 2009, Analytical and bioanalytical chemistry.

[76]  D. Chace,et al.  Use of tandem mass spectrometry for multianalyte screening of dried blood specimens from newborns. , 2003, Clinical chemistry.

[77]  N. Ozbek,et al.  Significant differences between capillary and venous complete blood counts in the neonatal period. , 2003, Clinical and laboratory haematology.

[78]  F. Zacchello,et al.  Method for the quantification of underivatized amino acids on dry blood spots from newborn screening by HPLC-ESI-MS/MS. , 2006, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[79]  R. Fingerhut,et al.  Stability of acylcarnitines and free carnitine in dried blood samples: implications for retrospective diagnosis of inborn errors of metabolism and neonatal screening for carnitine transporter deficiency. , 2009, Analytical chemistry.

[80]  K. Strauss,et al.  Second-tier test for quantification of alloisoleucine and branched-chain amino acids in dried blood spots to improve newborn screening for maple syrup urine disease (MSUD). , 2008, Clinical chemistry.

[81]  C. Damen,et al.  Application of dried blood spots combined with high-performance liquid chromatography coupled with electrospray ionisation tandem mass spectrometry for simultaneous quantification of vincristine and actinomycin-D , 2009, Analytical and bioanalytical chemistry.